Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q2 2020 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2020-08-13

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 13, 2020

Total Value: $51.63M (100.0% shares, 0.0% debt)

Holdings (13)

— IVERIC BIO INC 27.1%

Value $13.97M Shares 2,739,641 Est. Cost $1.52 Unrealized —

LGND LIGAND PHARMACEUTICALS 20.0%

Value $10.34M Shares 92,407 Est. Cost $56.68 Unrealized +11.9%

— CTI BIOPHARMA CORP 9.1%

Value $4.719M Shares 4,068,191 Est. Cost $2.16 Unrealized —

DMAC DIAMEDICA THERAPEUTICS INC 9.0%

Value $4.632M Shares 668,430 Est. Cost $4.13 Unrealized +7.9%

— CATALYST BIOSCIENCES INC 6.2%

Value $3.214M Shares 547,541 Est. Cost $5.11 Unrealized —

— NEOS THERAPEUTICS INC 5.9%

Value $3.046M Shares 4,447,026 Est. Cost $1.80 Unrealized —

XOMA XOMA CORP 5.7%

Value $2.968M Shares 150,213 Est. Cost $14.24 Unrealized +54.1%

— APOLLO ENDOSURGERY INC 4.6%

Value $2.367M Shares 1,447,765 Est. Cost $4.35 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 4.4%

Value $2.253M Shares 676,592 Est. Cost $5.80 Unrealized -37.3%

— ADAMAS PHARMACEUTICALS INC 3.8%

Value $1.94M Shares 757,704 Est. Cost $4.81 Unrealized —

— CERECOR INC 2.3%

Value $1.171M Shares 450,500 Est. Cost $2.60 Unrealized —

— PROGENITY INC 1.7%

Value $865K Shares 96,135 Est. Cost $9.00 Unrealized —

— BRICKELL BIOTECH INC 0.3%

Value $147K Shares 146,739 Est. Cost $1.00 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	IVERIC BIO INC	2,739,641	$13.97M	27.1%	$1.52	—	COM	46583P102
LGND	LIGAND PHARMACEUTICALS	92,407	$10.34M	20.0%	$56.68	+11.9%	COM NEW	53220K504
—	CTI BIOPHARMA CORP	4,068,191	$4.719M	9.1%	$2.16	—	COM	12648L601
DMAC	DIAMEDICA THERAPEUTICS INC	668,430	$4.632M	9.0%	$4.13	+7.9%	COM NEW	25253X207
—	CATALYST BIOSCIENCES INC	547,541	$3.214M	6.2%	$5.11	—	COM NEW	14888D208
—	NEOS THERAPEUTICS INC	4,447,026	$3.046M	5.9%	$1.80	—	COM	64052L106
XOMA	XOMA CORP	150,213	$2.968M	5.7%	$14.24	+54.1%	COM NEW	98419J206
—	APOLLO ENDOSURGERY INC	1,447,765	$2.367M	4.6%	$4.35	—	COM	03767D108
CPIX	CUMBERLAND PHARMACEUTICALS	676,592	$2.253M	4.4%	$5.80	-37.3%	COM	230770109
—	ADAMAS PHARMACEUTICALS INC	757,704	$1.94M	3.8%	$4.81	—	COM	00548A106
—	CERECOR INC	450,500	$1.171M	2.3%	$2.60	—	COM	15671L109
—	PROGENITY INC	96,135	$865K	1.7%	$9.00	—	COM	74319F107
—	BRICKELL BIOTECH INC	146,739	$147K	0.3%	$1.00	—	COM	10802T105